PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
34710829-4	2021	Here, we adopted a prodrug system that uses 5-fluorocytosine (5-FC) and a HER2-targeting scaffold protein, ZHER2:2891, fused with yeast cytosine deaminase (Fcy) to target HER2-overexpressing cancer cells and to convert 5-FC to a significantly more toxic chemotherapeutic, 5-fluorouracil (5-FU).	Flucytosine	44-60	glutamyl-tRNA(Gln) amidotransferase subunit HER2	Saccharomyces cerevisiae S288C	171-175	
34710829-4	2021	Here, we adopted a prodrug system that uses 5-fluorocytosine (5-FC) and a HER2-targeting scaffold protein, ZHER2:2891, fused with yeast cytosine deaminase (Fcy) to target HER2-overexpressing cancer cells and to convert 5-FC to a significantly more toxic chemotherapeutic, 5-fluorouracil (5-FU).	Flucytosine	62-66	glutamyl-tRNA(Gln) amidotransferase subunit HER2	Saccharomyces cerevisiae S288C	171-175	
34710829-4	2021	Here, we adopted a prodrug system that uses 5-fluorocytosine (5-FC) and a HER2-targeting scaffold protein, ZHER2:2891, fused with yeast cytosine deaminase (Fcy) to target HER2-overexpressing cancer cells and to convert 5-FC to a significantly more toxic chemotherapeutic, 5-fluorouracil (5-FU).	Flucytosine	219-223	glutamyl-tRNA(Gln) amidotransferase subunit HER2	Saccharomyces cerevisiae S288C	74-78